The pharmacovigilance and drug safety software market size was valued at USD 225.36 million in 2025 and is projected to grow from USD 40.91 million in 2026 to USD 421.99 million by 2034 at a CAGR of 7 ...

Researchers have demonstrated a new training technique that significantly improves the accuracy of graph neural networks (GNNs)—AI systems used in applications from drug discovery to weather ...

In another sign that the biotech IPO market is heating back up, Odyssey Therapeutics has made a fresh announcement of its ...

This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, ...

The 13-day win streaks in the Nasdaq Composite and Nasdaq 100 are about to end — unless both indexes climb into the green by ...

Unicycive Therapeutics, Inc. (UNCY) 25th Annual Needham Virtual Healthcare Conference April 15, 2026 3:45 PM EDTCompany ParticipantsShalabh Gupta - ...

A big reason is the high prices Americans pay for surgeries and drugs.

AI could streamline drug safety detection by identifying adverse events in EHR clinical notes, improving automation at Vanderbilt and UCSF.

The Middle East crisis led to a broad selloff in Russell equity segments in March, halting the year-long rally.